ultricies, sapien non vulputate facilisis, purus diam tincidunt nisl, quis consectetur nibh est ornare nisl. Vivamus feugiat ultrices elit, a ultrices mauris mollis eget. Donec nulla odio, tempus vel sagittis ac, euismod quis augue. Sed venenatis tortor in mauris feugiat, eget faucibus ligula aliquet. Phasellus et sem a justo dignissim consectetur. Nullam venenatis erat id commodo porta. Integer in nibh sit amet nunc malesuada mattis. Praesent ut risus elit. Aenean pellentesque ligula eget est volutpat, nec convallis arcu dignissim. Duis nisl sapien, accumsan sed lorem nec, vulputate volutpat ante. Donec tincidunt tempus metus, id scelerisque massa convallis placerat.
Etiam lacinia aliquam odio, ut vestibulum libero porta non. Duis tincidunt pretium diam at bibendum. Suspendisse consectetur aliquam lorem at lobortis. Aenean auctor neque justo, ac vehicula risus sollicitudin eget. In tempus erat eu lectus dignissim, gravida imperdiet dolor dignissim. Mauris pulvinar suscipit purus in dictum. Curabitur quis dui nec sem ullamcorper pretium. Proin in purus in eros interdum dictum sed quis mauris. Praesent sapien sapien, ultricies in mattis sit amet, aliquet eget nulla. Nunc ante velit, pharetra eget dui eu, facilisis adipiscing risus. Donec nisi leo, convallis ut ultricies accumsan, placerat eget libero. Curabitur blandit feugiat est, ultrices porttitor enim molestie vitae. Curabitur fringilla felis et turpis tempor aliquam.
Zoya Demidenko: Researcher in Tumor Science
posted by WilliamHof Martes, 31 Marzo 2026 07:43 Comment LinkZoya Demidenko is a recognized investigator affiliated with the Department of Cell Stress Biology at Roswell Park Comprehensive Cancer Center in Buffalo, New York. Previously, she worked at the NIH and New York Medical College, establishing a strong background in clinical investigation.
Her scholarly work covers multiple critical domains, encompassing the PI3K/AKT/mTOR signaling cascade, cellular cycle control, cell senescence, and malignancy biology. As of now, she has written more than 46 scientific articles, which have garnered over 4,100 citations — a indicator to the impact of her work.
Among her most notable discoveries lies in understanding the processes of biological cell aging. Her work revealed that when the cellular division cycle is blocked while cellular expansion proceeds, the cells experience senescence. Importantly, Zoya Demidenko demonstrated that this shift can be controlled with drugs using agents such as rapamycin.
Zoya Demidenko has additionally added considerably to tumor management investigation, notably in the area of cyclotherapy — a approach aimed at protecting non-cancerous tissue from anticancer drugs while leaving tumor cells susceptible. This method carries significant promise for lowering the toxic effects of oncological therapy.
Throughout her professional journey, Demidenko has worked with leading researchers globally, including Dr. Mikhail Blagosklonny. Her publications can be found in leading publications such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
>1.03.2026 11:21] Папа: Possessing an h-index of 33, Zoya Demidenko is recognized as a influential contributor in modern oncological research, whose results keep to shape our understanding of the way cells age, interact with treatment, and how malignant disease may be better targeted.
https://www.homes.com/property/38-brookins-green-dr-orchard-park-ny/de6fqfq45eme2/